IOVA
Iovance Biotherapeutics, Inc.
13.32
USD
This page is just a preview of the data found in TrendSpider’s full version
Iovance Biotherapeutics, Inc. stock is up 58.01% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 38.46% of the previous 13 October’s closed higher than September. In the last 10 Unusual Options Trades, there were 1 PUT, 9 CALLs. 80% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 08 Oct 15:55 | 15 Jan, 2027 | 10.00 | 22412 | ||
| 08 Oct 16:44 | 15 Jan, 2027 | 8.00 | 8787 | ||
| 08 Oct 17:13 | 18 Dec, 2026 | 12.50 | 3342 | ||
| 08 Oct 17:38 | 19 Jan, 2029 | 7.50 | 952 | ||
| 08 Oct 17:41 | 19 Jan, 2029 | 7.50 | 952 | ||
| 08 Oct 17:55 | 18 Dec, 2026 | 10.00 | 8129 | ||
| 08 Oct 18:43 | 15 Jan, 2027 | 8.00 | 8787 | ||
| 08 Oct 18:52 | 15 Jan, 2027 | 10.00 | 31841 | ||
| 08 Oct 18:54 | 15 Jan, 2027 | 3.00 | 14127 | ||
| 08 Oct 19:57 | 18 Dec, 2026 | 10.00 | 8129 |
-
BairdThu Oct 8, 13:50
-
Wells FargoWed Sep 30, 16:46
-
HC Wainwright & Co.Tue Sep 29, 16:35
-
Goldman SachsThu Sep 24, 15:54
-
BarclaysThu Sep 17, 14:17
-
Noah Berkowitz, Chief Medical Officershares awarded
-
Noah Berkowitz, Chief Medical Officershares awarded
-
Noah Berkowitz, Chief Medical Officershares awarded
-
Frederick G Vogt, Interim CEO & General Counselshares converted
-
Igor Bilinsky, Chief Operating Officershares converted
-
Raj K Puri, Chief Regulatory Officershares converted
Looking for a new broker?
Today’s Movers and Shakers
Join Our Market Watch Newsletter!
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!
